Linus Health

Bringing together decades of research on neurological diseases, artificial intelligence (AI), neuroscience, speech analytics, speech pathology, and mobile software platforms for health monitoring, Aural Analytics has built proprietary metrics that use speech to capture changes in neurological health. With Aural Analytics’ downloadable apps, any smartphone or tablet becomes a powerful brain health monitor. This technology augments traditional functional rating scales commonly used to measure neurological health in clinical trials with objective, interpretable, and continuous outcomes. In turn, this results in more reliable and higher resolution outcomes for evaluating the effectiveness of drugs or other interventions. Aural Analytics’ technology can reveal the incremental changes that occur as a patient progresses from one point on a functional rating scale to the next.

Kinesis Health Technologies is an award-winning digital health company offering solutions for assessment of physical function as well as prevention and assessment of falls risk in older adults. Our medical device technologies are patent protected and based on 12 years of research conducted in Ireland. Our team has extensive business, marketing, and technical experience. Kinesis Health Technologies was founded in 2013 and are based in Dublin, Ireland.

Digital Cognition Technologies, Inc. specializes in the research and development of non-invasive tests designed to detect presymptomatic cognitive impairment. The company’s innovative approach involves analyzing micro-movements in drawing behavior, which provide insights into an individual's memory and thinking processes. These tests are utilized in various contexts, including drug development, where they facilitate the pre-screening of participants and help assess the efficacy of treatments by identifying subtle cognitive changes. Additionally, the tests support researchers in early detection and intervention strategies, enabling timely treatment with both investigational therapies and established medications. Founded in 2015 and based in Waltham, Massachusetts, Digital Cognition Technologies aims to enhance patient care and improve treatment outcomes through early identification of cognitive decline.